Engineering new medicine: an interview with James Collins.
At first glance, the commonality among synthetic gene networks, nerve cell response times and the emergence of antibiotic resistance is obscure. Yet, when speaking with James (Jim) Collins, the relationship becomes clear: all are applications-oriented problems, and all inspire unique approaches from this unusual engineer who is empowered by his freedom to fail.
Collins
James
J
Center for BioDynamics, Boston University, MA, USA. collins@bu.edu
D057005:Bioengineering; D055808:Drug Discovery / Q000266:history*; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans